PRINCIPAL DISPLAY PANEL - 2,000 Units/mL Vial Label
NDC 0069-1305-01
Rx only
Retacrit®
Epoetin Alfa-epbx
recombinant
2,000 Units/mL
1 mL single-dose vial
Pfizer Oncology
PRINCIPAL DISPLAY PANEL - 2,000 Units/mL Vial Carton
Retacrit®
Epoetin Alfa-epbx
recombinant
2,000 Units/mL
NDC 0069-1305-10
Rx only
ALWAYS DISPENSE ENCLOSED MEDICATION
GUIDE TO EACH PATIENT
10 x 2,000 Units/mL single-dose vials (containing 1 mL)
Phenylketonurics: Contains Phenylalanine,
0.5 mg per mL
For Intravenous or Subcutaneous Use Only
Single-dose vial
Discard unused portion
Pfizer Oncology
PRINCIPAL DISPLAY PANEL - 3,000 Units/mL Vial Label
NDC 0069-1306-01
Rx only
Retacrit®
Epoetin Alfa-epbx
recombinant
3,000 Units/mL
1 mL single-dose vial
Pfizer Oncology
PRINCIPAL DISPLAY PANEL - 3,000 Units/mL Vial Carton
Retacrit®
Epoetin Alfa-epbx
recombinant
3,000 Units/mL
NDC 0069-1306-10
Rx only
ALWAYS DISPENSE ENCLOSED MEDICATION
GUIDE TO EACH PATIENT
10 x 3,000 Units/mL single-dose vials (containing 1 mL)
Phenylketonurics: Contains Phenylalanine,
0.5 mg per mL
For Intravenous or Subcutaneous Use Only
Single-dose vial
Discard unused portion
Pfizer Oncology
PRINCIPAL DISPLAY PANEL - 4,000 Units/mL Vial Label
NDC 0069-1307-01
Rx only
Retacrit®
Epoetin Alfa-epbx
recombinant
4,000 Units/mL
1 mL single-dose vial
Pfizer Oncology
PRINCIPAL DISPLAY PANEL - 4,000 Units/mL Vial Carton
Retacrit®
Epoetin Alfa-epbx
recombinant
4,000 Units/mL
NDC 0069-1307-10
Rx only
ALWAYS DISPENSE ENCLOSED MEDICATION
GUIDE TO EACH PATIENT
10 x 4,000 Units/mL single-dose vials (containing 1 mL)
Phenylketonurics: Contains Phenylalanine,
0.5 mg per mL
For Intravenous or Subcutaneous Use Only
Single-dose vial
Discard unused portion
Pfizer Oncology
PRINCIPAL DISPLAY PANEL - 10,000 Units/mL Vial Label
NDC 0069-1308-01
Rx only
Retacrit®
Epoetin Alfa-epbx
recombinant
10,000 Units/mL
1 mL single-dose vial
Pfizer Oncology
PRINCIPAL DISPLAY PANEL - 10,000 Units/mL Vial Carton
Retacrit®
Epoetin Alfa-epbx
recombinant
10,000 Units/mL
NDC 0069-1308-10
Rx only
ALWAYS DISPENSE ENCLOSED MEDICATION
GUIDE TO EACH PATIENT
10 x 10,000 Units/mL single-dose vials (containing 1 mL)
Phenylketonurics: Contains Phenylalanine,
0.5 mg per mL
For Intravenous or Subcutaneous Use Only
Single-dose vial
Discard unused portion
Pfizer Oncology
PRINCIPAL DISPLAY PANEL - 40,000 Units/mL Vial Label
NDC 0069-1309-01
Rx only
Retacrit®
Epoetin Alfa-epbx
recombinant
40,000 Units/mL
1 mL single-dose vial
Pfizer Oncology
PRINCIPAL DISPLAY PANEL - 40,000 Units/mL Vial Carton
Retacrit®
Epoetin Alfa-epbx
recombinant
40,000 Units/mL
NDC 0069-1309-04
Rx only
ALWAYS DISPENSE ENCLOSED MEDICATION GUIDE TO EACH PATIENT
4 x 40,000 Units/mL single-dose vials (containing 1 mL)
Phenylketonurics: Contains Phenylalanine, 0.5 mg per mL
For Intravenous or Subcutaneous Use Only
Single-dose vial
Discard unused portion
Pfizer Oncology
PRINCIPAL DISPLAY PANEL - 20,000 Units/mL Vial Label
NDC 0069-1311-01
Rx only
Retacrit®
Epoetin Alfa-epbx
recombinant
20,000 Units/mL
1 mL Multiple-Dose Vial
Pfizer Oncology
PRINCIPAL DISPLAY PANEL - 20,000 Units/mL Vial Carton
ALWAYS DISPENSE ENCLOSED MEDICATION GUIDE TO EACH PATIENT
10 x 20,000 Units/mL multiple-dose vials (containing 1 mL)
NDC 0069-1311-10
Retacrit®
Epoetin Alfa-epbx
recombinant
20,000 Units/mL
For Intravenous or Subcutaneous Use Only
Sterile Solution - Preserved
Multiple-Dose Vials
Rx only
PRINCIPAL DISPLAY PANEL - 20,000 Units/2 mL Vial Label
NDC 0069-1318-01
Rx only
Retacrit®
Epoetin Alfa-epbx
recombinant
20,000 Units/2 mL
(10,000 Units/mL)
2 mL Multiple-Dose Vial
Pfizer Oncology
PRINCIPAL DISPLAY PANEL - 20,000 Units/2 mL Vial Carton
ALWAYS DISPENSE ENCLOSED MEDICATION GUIDE TO EACH PATIENT
NDC 0069-1318-10
10 x 20,000 Units/2 mL (10,000 Units/mL) multiple-dose vials (containing 2 mL)
Retacrit®
Epoetin Alfa-epbx
recombinant
20,000 Units/2 mL (10,000 Units/mL)
For Intravenous or Subcutaneous Use Only
Sterile Solution - Preserved
Multiple-Dose Vials
Rx only
